Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia).

María Adelaida GómezAdriana NavasMiguel Dario PrietoLina Giraldo-ParraAlexandra CossioNeal AlexanderNancy Gore Saravia

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Our results quantitatively portray the immune dynamics of therapeutic healing, and provide the knowledge base for optimization of antimonial drug treatments, guiding the selection and/or design of targeted drug delivery systems and strategies for targeted immunomodulation.

Keyphrases

cancer therapy
healthcare
drug delivery
emergency department
adverse drug